Uridine-5′-triphosphate (UTP) maintains cardiac mitochondrial function following chemical and hypoxic stress

Journal of Molecular and Cellular Cardiology

Volumn 43, Issue 5, 2007, Pages 653-662

  Yitzhaki, Smadar ^a   Hochhauser, Edith ^b   Porat, Eyal ^b   Shainberg, Asher ^a  

^a BAR ILAN UNIVERSITY   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Cardioprotection; Chemical stress; Hypoxia; Mitochondrial membrane potential; UTP

Indexed keywords

5 HYDROXYDECANOIC ACID; ADENOSINE TRIPHOSPHATE; CALCIUM CHELATING AGENT; CIBACRON BLUE F3GA; CYTOCHROME C OXIDASE; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID; LACTATE DEHYDROGENASE; POTASSIUM CHANNEL BLOCKING AGENT; PURINE P2Y RECEPTOR; PURINERGIC RECEPTOR BLOCKING AGENT; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); ROTENONE; SODIUM AZIDE; SUCCINATE DEHYDROGENASE (UBIQUINONE); URIDINE TRIPHOSPHATE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CHEMICAL STRESS; CONTROLLED STUDY; CORONARY ARTERY LIGATION; ENZYME RELEASE; HEART MITOCHONDRION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HYPOXIA; IN VITRO STUDY; IN VIVO STUDY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MEMBRANE DEPOLARIZATION; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; NEWBORN; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; RESPIRATORY CHAIN; ANIMAL; CELL CULTURE; CELL HYPOXIA; CELL MEMBRANE POTENTIAL; CYTOLOGY; DRUG EFFECT; HEART MUSCLE CELL; METABOLISM; PHYSIOLOGY; WISTAR RAT;

RATTUS;

ADENOSINE TRIPHOSPHATE; ANIMALS; ANIMALS, NEWBORN; CELL HYPOXIA; CELLS, CULTURED; ELECTRON TRANSPORT COMPLEX IV; L-LACTATE DEHYDROGENASE; MEMBRANE POTENTIALS; MITOCHONDRIA, HEART; MITOCHONDRIAL MEMBRANES; MYOCYTES, CARDIAC; RATS; RATS, WISTAR; URIDINE TRIPHOSPHATE;

EID: 35348972413     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2007.07.060     Document Type: Article

References (32)

1. Mitchell P. Coupling of phosphorylation to electron and hydrogen transport by a chemi-osmotic type of mechanism. Nature 191 (1961) 144-148
2. Di Lisa F., Menabo R., Canton M., and Petronilli V. The role of mitochondria in the salvage and the injury of the ischemic myocardium. Biochim. Biophys. Acta 1366 (1998) 69-78
3. Jacobson K.A., Jarvis M.F., and Williams M. Purine and pyrimidine (P2) receptors as drug targets. J. Med. Chem. 45 (2002) 4057-4093
4. Abbracchio M.P., and Burnstock G. Purinergic signalling: pathophysiological roles. Jpn. J. Pharmacol. 78 (1998) 113-145
5. Yitzhaki S., Shneyvays V., Jacobson K.A., and Shainberg A. Involvement of uracil nucleotides in protection of cardiomyocytes from hypoxic stress. Biochem. Pharmacol. 69 (2005) 1215-1223
6. Yitzhaki S., Shainberg A., Cheporko Y., Vidne B.A., Sagie A., Jacobson K.A., et al. Uridine-5′-triphosphate (UTP) reduces infarct size and improves rat heart function after myocardial infarct. Biochem. Pharmacol. 72 (2006) 949-955
7. 3 receptor activation during hypoxia in isolated rat cardiac myocytes. Mol. Cell. Biochem. 217 (2001) 143-152
8. 3 adenosine receptor agonist. Exp. Cell Res. 243 (1998) 383-397
9. Shneyvays V., Safran N., Halili-Rutman I., and Shainberg A. Insights into adenosine A1 and A3 receptors function: cardiotoxicity and cardioprotection. Drug Dev. Res. 50 (2000) 324-337
10. Shoshan-Barmatz V., and Gincel D. The voltage-dependent anion channel: characterization, modulation, and role in mitochondrial function in cell life and death. Cell Biochem. Biophys. 39 (2003) 279-292
11. 3 adenosine receptor protects against doxorubicin-induced cardiotoxicity. J. Mol. Cell. Cardiol. 33 (2001) 1249-1261
12. Duchen M.R., Surin A., and Jacobson J. Imaging mitochondrial function in intact cells. Methods Enzymol. 361 (2003) 353-389
13. Kolosova N.G., and Kolpakov A.R. Measurement of mitochondrial transmembrane electric potential using the fluorescent probe DSM. Biofizika 36 (1991) 802-804
14. Scaduto Jr. R.C., and Grotyohann L.W. Measurement of mitochondrial membrane potential using fluorescent rhodamine derivatives. Biophys. J. 76 (1999) 469-477
15. 3 receptors protects mitochondria during hypoxia in cardiomyocytes by distinct mechanisms. In: Dhalla N.S., Takeda N., Singh M., and Lukas A. (Eds). Myocardial Ischemia and Preconditioning (2003), Kluwer Academic Publishers, Boston 347-364
16. Maklashina E., Sher Y., Zhou H.Z., Gray M.O., Karliner J.S., and Cecchini G. Effect of anoxia/reperfusion on the reversible active/de-active transition of NADH-ubiquinone oxidoreductase (Complex I) in rat heart. Biochim. Biophys. Acta 1556 (2002) 6-12
17. Maklashina E., Kotlyar A.B., Karliner J.S., and Cecchini G. Effect of oxygen on activation state of Complex I and lack of oxaloacetate inhibition of Complex II in Langendorff perfused rat heart. FEBS Lett. 556 (2004) 64-68
18. Kotlyar A.B., and Vinogradov A.D. Slow active/inactive transition of the mitochondrial NADH-ubiquinone reductase. Biochim. Biophys. Acta 1019 (1990) 151-158
19. Shneyvays V., Leshem D., Shmist Y., Zinman T., and Shainberg A. Effects of menadione and its derivative on cultured cardiomyocytes with mitochondrial disorders. J. Mol. Cell. Cardiol. 39 (2005) 149-158
20. Harvey J., Hardy S.C., and Ashford M.L. Dual actions of the metabolic inhibitor, sodium azide on K(ATP) channel currents in the rat CRI-G1 insulinoma cell line. Br. J. Pharmacol. 126 (1999) 51-60
21. Rakhit R.D., Mojet M.H., Marber M.S., and Duchen M.R. Mitochondria as targets for nitric oxide-induced protection during simulated ischemia and reoxygenation in isolated neonatal cardiomyocytes. Circulation 103 (2001) 2617-2623
22. Riepe M.W., Niemi W.N., Megow D., Ludolph A.C., and Carpenter D.O. Mitochondrial oxidation in rat hippocampus can be preconditioned by selective chemical inhibition of succinic dehydrogenase. Exp. Neurol. 138 (1996) 15-21
23. Park J.W., Chun Y.S., Kim Y.H., Kim C.H., and Kim M.S. Ischemic preconditioning reduces Op6 generation and prevents respiratory impairment in the mitochondria of post-ischemic reperfused heart of rat. Life Sci. 60 (1997) 2207-2219
24. Kadenbach B. Intrinsic and extrinsic uncoupling of oxidative phosphorylation. Biochim. Biophys. Acta 1604 (2003) 77-94
25. Belous A., Wakata A., Knox C.D., Nicoud I.B., Pierce J., Anderson C.D., et al. Mitochondrial P2Y-Like receptors link cytosolic adenosine nucleotides to mitochondrial calcium uptake. J. Cell. Biochem. 92 (2004) 1062-1073
26. Lesnefsky E.J., Moghaddas S., Tandler B., Kerner J., and Hoppel C.L. Mitochondrial dysfunction in cardiac disease: ischemia-reperfusion, aging, and heart failure. J. Mol. Cell. Cardiol. 33 (2001) 1065-1089
27. Holmuhamedov E.L., Jahangir A., Oberlin A., Komarov A., Colombini M., and Terzic A. Potassium channel openers are uncoupling protonophores: implication in cardioprotection. FEBS Lett. 568 (2004) 167-170
28. Stuart J.A., Cadenas S., Jekabsons M.B., Roussel D., and Brand M.D. Mitochondrial proton leak and the uncoupling protein 1 homologues. Biochim. Biophys. Acta 1504 (2001) 144-158
29. 2+ overload in rat cardiac mitochondria. J. Physiol. 519 Pt 2 (1999) 347-360
30. Sack M.N. Mitochondrial depolarization and the role of uncoupling proteins in ischemia tolerance. Cardiovasc. Res. 72 (2006) 210-219
31. Brennan J.P., Southworth R., Medina R.A., Davidson S.M., Duchen M.R., and Shattock M.J. Mitochondrial uncoupling, with low concentration FCCP, induces ROS-dependent cardioprotection independent of KATP channel activation. Cardiovasc. Res. 72 (2006) 313-321
32. Rodrigo G.C., Lawrence C.L., and Standen N.B. Dinitrophenol pretreatment of rat ventricular myocytes protects against damage by metabolic inhibition and reperfusion. J. Mol. Cell. Cardiol. 34 (2002) 555-569